These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19953500)

  • 1. Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins.
    van Hunsel F; van Puijenbroek E; de Jong-van den Berg L; van Grootheest K
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):26-32. PubMed ID: 19953500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
    Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
    Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.
    van Hunsel F; Passier A; van Grootheest K
    Br J Clin Pharmacol; 2009 May; 67(5):558-64. PubMed ID: 19552751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
    Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
    Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cataracts and statins. A disproportionality analysis using data from VigiBase.
    Macías Saint-Gerons D; Bosco Cortez F; Jiménez López G; Castro JL; Tabarés-Seisdedos R
    Regul Toxicol Pharmacol; 2019 Dec; 109():104509. PubMed ID: 31669197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic adverse drug reactions: a case/non-case study in Italy.
    Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
    Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
    Fujimoto M; Hosomi K; Takada M
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
    Pariente A; Daveluy A; Laribière-Bénard A; Miremont-Salame G; Begaud B; Moore N
    Drug Saf; 2009; 32(5):441-7. PubMed ID: 19419238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
    Aagaard L; Nielsen LH; Hansen EH
    Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database.
    Capogrosso Sansone A; Convertino I; Galiulo MT; Salvadori S; Pieroni S; Knezevic T; Mantarro S; Marino A; Hauben M; Blandizzi C; Tuccori M
    Drug Saf; 2017 Oct; 40(10):895-909. PubMed ID: 28681266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
    di Mauro G; Zinzi A; Scavone C; Mascolo A; Gaio M; Sportiello L; Ferrajolo C; Rafaniello C; Rossi F; Capuano A
    Drug Saf; 2021 Mar; 44(3):337-349. PubMed ID: 33351170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.
    Golomb BA; Verden A; Messner AK; Koslik HJ; Hoffman KB
    Drug Saf; 2018 Apr; 41(4):403-413. PubMed ID: 29427042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-induced myasthenia: A disproportionality analysis of the WHO's VigiBase pharmacovigilance database.
    Gras-Champel V; Batteux B; Masmoudi K; Liabeuf S
    Muscle Nerve; 2019 Oct; 60(4):382-386. PubMed ID: 31298743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea.
    Kim H; Kim N; Lee DH; Kim HS
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):409-413. PubMed ID: 28500776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase
    Montastruc F; Benevent J; Rousseau V; Durrieu G; Sommet A; Montastruc JL
    Fundam Clin Pharmacol; 2019 Feb; 33(1):108-112. PubMed ID: 30098074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin safety: an appraisal from the adverse event reporting system.
    Davidson MH; Clark JA; Glass LM; Kanumalla A
    Am J Cardiol; 2006 Apr; 97(8A):32C-43C. PubMed ID: 16581327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase.
    Edwards IR; Star K; Kiuru A
    Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.